Skip to main content

Table 5 Inter-relationships between the clinicopathological characteristics in patients with ER negative primary operable invasive ductal breast cancer (n = 124)

From: The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer

 

  Size

  Grade

Involved lymph node

PR status

HER-2 status

Ki-67 status

  LVI

  MVD

Loco-regional treatment

Systemic treatment

 

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

Age (≤50/>50 years)

0.241

0.908

0.242

0.002

0.154

0.772

0.826

0.347

0.282

0.059

Size (≤20/21-50/>50 mm)

 

0.181

0.004

0.131

0.343

0.085

0.011

0.106

0.042

0.151

Grade (I/II/III)

  

0.127

0.049

0.730

0.586

0.042

0.586

0.980

0.164

Involved lymph node (0/1-3/>3)

   

0.166

0.058

0.392

<0.001

0.068

0.013

0.118

Progesterone –receptor status (PR-/PR+)

    

0.769

0.985

0.111

0.191

0.093

0.272

HER-2 status (HER-2 -/HER-2+)

     

0.949

0.001

0.340

0.068

0.292

Ki-67 proliferative activity (Low Ki-67/High Ki-67)

      

0.739

0.651

0.256

0.335

LVI (Absent/Present)

       

0.414

0.054

0.563

MVD (tertiles 1, 2, 3)

        

0.020

0.944

Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy)

         

0.432

  1. Bold data reflects an association between the two variables.